SSX5 is a cancer-testis antigen and member of the highly homologous SSX gene family located on the X chrX 1. The protein is localized to the nucleus where it is diffusely distributed and may associate with polycomb-group nuclear bodies 2. SSX5 likely functions as a transcriptional modulator, with studies suggesting SSX proteins may act as transcriptional repressors 2. SSX5 is aberrantly expressed in multiple malignancies including melanoma, multiple myeloma, prostate cancer, and other cancers, though expression remains absent in most normal tissues except testis and weak thyroid expression 13. In multiple myeloma, SSX5 is expressed in approximately 20-35% of patients, and co-expression of SSX1, SSX2, SSX4, and SSX5 correlates with adverse prognosis and reduced survival 45. In prostate cancer, SSX5 expression is restricted to metastatic lesions with no detection in primary tumors 6. The clinical significance of SSX5 lies in its potential as an immunotherapy target. Cancer-testis antigens including SSX5 can induce systemic immune responses, particularly following allogeneic stem cell transplantation 4. SSX family members are considered promising candidates for cancer vaccines and immune-based therapeutic strategies 56.